Synergistic combination of two antimicrobial agents closing each other’s mutant selection windows to prevent antimicrobial resistance
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synergistic combination of two antimicrobial agents closing each other’s mutant selection windows to prevent antimicrobial resistance
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-05-02
DOI
10.1038/s41598-018-25714-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oral presentations
- (2017) INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pharmacodynamics of tigecycline alone and in combination with colistin against clinical isolates of multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model
- (2017) Xuejiu Cai et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antibiotic combination therapy can select for broad-spectrum multidrug resistance in Pseudomonas aeruginosa
- (2016) Martin Vestergaard et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pharmacokinetically-based prediction of the effects of antibiotic combinations on resistant Staphylococcus aureus mutants: in vitro model studies with linezolid and rifampicin
- (2016) Alexander A. Firsov et al. JOURNAL OF CHEMOTHERAPY
- Pilot Screening to Determine Antimicrobial Synergies in a Multidrug-Resistant Bacterial Strain Library
- (2016) Si-Hyun Kim et al. Microbial Drug Resistance
- Rapid antimicrobial susceptibility test for identification of new therapeutics and drug combinations against multidrug-resistant bacteria
- (2016) Wei Sun et al. Emerging Microbes & Infections
- Antimicrobial Activity of Fosfomycin-Tobramycin Combination against Pseudomonas aeruginosa Isolates Assessed by Time-Kill Assays and Mutant Prevention Concentrations
- (2015) María Díez-Aguilar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multidrug evolutionary strategies to reverse antibiotic resistance
- (2015) M. Baym et al. SCIENCE
- A new strategy to fight antimicrobial resistance: the revival of old antibiotics
- (2014) Nadim Cassir et al. Frontiers in Microbiology
- Advances in MRSA drug discovery: where are we and where do we need to be?
- (2013) Michio Kurosu et al. Expert Opinion on Drug Discovery
- Comparative study of the mutant prevention concentrations of vancomycin alone and in combination with levofloxacin, rifampicin and fosfomycin against methicillin-resistant Staphylococcus epidermidis
- (2013) Li-guang Liu et al. JOURNAL OF ANTIBIOTICS
- In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii
- (2013) Wentao Ni et al. JOURNAL OF ANTIBIOTICS
- New Azalomycin F Analogs from Mangrove Streptomyces sp. 211726 with Activity against Microbes and Cancer Cells
- (2013) Ganjun Yuan et al. Marine Drugs
- Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
- (2012) P. D. Tamma et al. CLINICAL MICROBIOLOGY REVIEWS
- Improving known classes of antibiotics: an optimistic approach for the future
- (2012) Karen Bush CURRENT OPINION IN PHARMACOLOGY
- Staphylococcus aureus Persisters Tolerant to Bactericidal Antibiotics
- (2012) Sabrina Lechner et al. JOURNAL OF MOLECULAR MICROBIOLOGY AND BIOTECHNOLOGY
- Combination therapies for combating antimicrobial resistance
- (2011) Michael A Fischbach CURRENT OPINION IN MICROBIOLOGY
- Synergy Testing by Etest, Microdilution Checkerboard, and Time-Kill Methods for Pan-Drug-Resistant Acinetobacter baumannii
- (2010) M. M. Sopirala et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The 10 × ‘20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020
- (2010) CLINICAL INFECTIOUS DISEASES
- Vancomycin in Combination with Other Antibiotics for the Treatment of Serious Methicillin‐ResistantStaphylococcus aureusInfections
- (2009) Stan Deresinski CLINICAL INFECTIOUS DISEASES
- Role of persisters and small-colony variants in antibiotic resistance of planktonic and biofilm-associated Staphylococcus aureus: an in vitro study
- (2009) R. Singh et al. JOURNAL OF MEDICAL MICROBIOLOGY
- In Vitro Evaluation of CBR-2092, a Novel Rifamycin-Quinolone Hybrid Antibiotic: Microbiology Profiling Studies with Staphylococci and Streptococci
- (2008) G. T. Robertson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Enrichment of resistant Staphylococcus aureus at ciprofloxacin concentrations simulated within the mutant selection window: bolus versus continuous infusion
- (2008) Alexander A. Firsov et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started